Shareholders meeting

To To Date: August 26, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Notice of the 39th Annual General Meeting (AGM) of the Company for the Financial Year 2025-26 under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). Dear Sir/Madam, In continuation of our previous communication and in line with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations'), attached herewith is the Notice and the Explanatory Statement of the 39th Annual General Meeting of the Company scheduled to be held on Thursday, September 24, 2026 at 11:30 A.M. (IST) through Video Conferencing / Other Audio-Visual Means (“VC/OAVM”) facility which is being circulated to our members by email in accordance with the applicable provisions of the Companies Act, 2013 and rules made thereunder. The said Notice forms part of the Annual Report 2025-26. The Annual Report for FY 2025-26 and other related documents are available on the website of the Company at www.balpharma.com Weblink : https://www.balpharma.com/balpharmacom/pdf/investors/ar/ar2025-2026.pdf Brief Information at a glance: Particulars Date 39th Annual General Meeting Thursday, September 24, 2026 at 11:30 A.M. Record Date for Final Dividend Cut-off Date for E-voting Thursday, September 17, 2026 Book Closure Period Friday, September 18, 2026 to Thursday, September 24, 2026 (both days inclusive) Commencement of E-voting Monday, September 21, 2026 at 9:00 A.M. End of E-voting Wednesday, September 23, 2026 at 5:00 P.M. Mode Video Conference (‘VC’) and Other Audio-Visual Means (‘OAVM’) Link for e- voting & participation in Members may access the same at the AGM through VC/OAVM https://www.evoting.nsdl.com under Shareholders/Members login by using the remote e-voting credentials E-Voting website NSDL : https://www.evoting.nsdl.com CDSL : https://evoting.cdslindia.com/Evoting/EvotingLogin Please takes this intimation on your records Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 Enclosure: AGM Notice AGM at a Glance 39th Annual General Meeting of Bal Pharma Limited - Information at a Glance Sl No P articulars D e t a i ls 01 Day, Date and Time of the AGM Thursday, 24th September, 2026, 11:30 A.M 02 Mode Video Conference (‘VC’) and Other Audio-Visual Means ( ‘OAVM’) 03 Link for e- voting & participation Members may access the same at in the AGM through VC/OAVM www.evoting.nsdl.com under Shareholders/Members login by using the remote e-voting credentials 04 Helpline number for VC participation NSDL: 022 - 4886 7000 and e-voting CDSL: 1800-21-09911 05 Email IDs for any assistance or support NSDL: evoting@nsdl.co.in for VC participation and e-voting CDSL: evoting@cdslindia.com 06 Record Date / Cut-off date for e-voting 17th September, 2026 07 Book closure Friday, 18th September, 2026 to Thursday, 24th September, 2026 (both days inclusive) 08 E-voting start time and date 21st September, 2026 (9:00 am IST) 09 E-voting end time and date 23rd September, 2026 (5:00 pm IST) 10 E-Voting website NSDL : www.evoting.nsdl.com CDSL : www.evoting.cdslindia.com/Evoting/EvotingLogin 11 Record date for Final dividend for 17th September, 2026 Financial Year 2025-26 12 Company Contact details for Speaker investor@balpharma.com registration and any other matters 13 Company Website for download AGM www.balpharma.com Notice & Annual report AGM NOTICE NOTICE is hereby given that the 39th (Thirty Ninth) Annual “RESOLVED THAT pursuant to the provisions of Section 152 and General Meeting (AGM) of the Members of Bal Pharma Limited will other applicable provisions, if any, of the Companies Act, 2013, the be held on Thursday, 24th September, 2026 at 11:30 A.M through Companies (Appointment and Qualification of Directors) Rules, Video Conference (“VC”) / Other Audio Visual Means (“OAVM”), to 2014, Regulation 17 of the SEBI (Listing Obligations and Disclosure transact the following business: Requirements) Regulations, 2015, and the Articles of Association of the Company, Mr. Ravindra Kumar Kothari (DIN : 03418320), who ORDINARY BUSINESS: retires by rotation at this meeting, being eligible and having offered himself for re-appointment, be and is hereby re-appointed as a 1. To receive, consider and adopt the Audited Standalone and Director of the Company. Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, the Statement of Profit and Loss for the SPECIAL BUSINESS: financial year ended as on that date and the Cash Flow Statement together with the Reports of the Board of Directors and the 4. To ratify the remuneration payable to Cost Auditors for the Auditors thereon. FinancialY ear 2026-27. To consider and if thought fit, to adopt the following resolution as an To consider and if thought fit, to adopt the following resolution as an Ordinary Resolution: Ordinary Resolution: “RESOLVED THAT the Audited Annual Financial Statements “RESOLVED THAT pursuant to the provisions of Section 148 (including the balance sheet of the Company as at March 31, 2026 and and other applicable provisions, if any, of the Companies Act, 2013 the statement of profit and loss together with the notes on accounts, and the Companies (Audit and Auditors) Rules, 2014 (including any schedules, statement of cash flow, etc.), in the prescribed format, statutory modifications or re-enactment thereof), the remuneration annexed to and forming part of the accounts for the year ended payable to Messrs. GNV & Associates, Cost Auditors (Firm March 31, 2026, including the consolidated financial statements for Registration No.000150), appointed by the Board of Directors the year ended as on that date, together with the reports of the based on the recommendation of the Audit Committee of the Board of Directors’ and Auditors’ thereon, be and are hereby Company to conduct the audit of the Cost records of the Company approved and adopted.” for the Financial Year 2026-27, amounting to Rs. 75,000/- (Rupees Seventy Five Thousand only) or such other amount(s) as may be 2. To declare dividend of Rs. 1.20 per Equity Share of Rs 10/- decided by the Board including applicable taxes and excluding out of each. pocket expenses incurred by them in connection with the audit of cost records, be and is hereby ratified and approved. To consider and if thought fit, to adopt the following resolution as an Ordinary Resolution: RESOLVED FURTHER THAT any of the Board of Directors or Company Secretary of the Company be and are hereby authorized to "RESOLVED THAT pursuant to the provisions of Section 123 and do all such acts, deeds, matters and things as may be considered other applicable provisions, if any, of the Companies Act, 2013, read necessary and expedient in order to give effect to the above said with the Companies (Declaration and Payment of Dividend) Rules, Resolution.” 2014, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Articles of Association of the Company, a 5. To renew contract with Messrs. Desa Marketing dividend of Rs. 1.20 (Rupees One and Twenty Paise only) per Equity International. Share of Rs. 10/- each (i.e., 12% on the face value of the Equity Shares) for the Financial Year ended March 31, 2026, as recommended by the To consider and if thought fit to adopt the following Resolution as Board of Directors, be and is hereby declared and the same be paid to Ordinary Resolution: those Members whose names appear in the Register of Members / List of Beneficial Owners maintained by the Depositories as on the “RESOLVED THAT pursuant to Regulation 23 of SEBI (Listing Record Date fixed for [Showing first 8,000 characters — download PDF for full document]